Umbilical Cord Mesenchymal Stem Cell Therapy · Tijuana, Mexico
The future of advanced healing and recovery is now.
Stem cells, particularly umbilical cord–derived mesenchymal stem cells (UC-MSCs), stand at the forefront of modern medical research — offering groundbreaking, ethically-sourced solutions for a wide range of degenerative and chronic conditions.
The Science
From a single umbilical cord, the body's own repair kit.
Regenerative medicine harnesses the body's inherent healing mechanisms — stem cell therapy and immune modulation — to repair damage that the body cannot resolve on its own. Here is the biology behind the treatment, in plain terms.
Adult stem cells,
not embryonic.
Human stem cells fall into two categories: embryonic and adult. Embryonic stem cells are controversial and carry a real risk of uncontrolled growth, as they are sourced from human embryos. None of the products used in treatment at Biostem contain embryonic stem cells or involve aborted fetal tissue.
Adult stem cells are instead harvested from tissue sources such as umbilical cord, bone marrow, and adipose tissue — from consenting donors, with no ethical conflict. Current research overwhelmingly favors adult stem cells for clinical use, given their targeted differentiation potential, accessibility, and negligible risk of tumor formation.
Mesenchymal stem cells (MSCs).
Mesenchymal stem cells are a class of adult stem cells with self-renewal, anti-inflammatory, signaling, and multi-lineage differentiation properties. Because they are not sourced from embryonic material, MSCs present no ethical concern — and a deep body of in-vitro and in-vivo research supports their mechanism, safety, and clinical efficacy across a wide range of degenerative conditions.
Why umbilical cord (UC-MSC)?
Not all MSCs are equal. Umbilical cord tissue — specifically Wharton's Jelly, the gelatinous matrix that cushions the cord's vessels — yields cells that are younger, more proliferative, and less immunologically reactive than MSCs sourced from bone marrow or adipose tissue.
Compared to bone-marrow-derived MSCs, Wharton's Jelly MSCs show increased division and telomerase activity, and no HLA Class I expression — meaning no risk of immune rejection. They can be directed toward osteoblasts, chondrocytes, adipocytes, myocytes, cardiomyocytes, glial cells, and dopaminergic neurons, and are collected non-invasively from ethically donated, full-term cesarean births — tissue once discarded as medical waste.
Cytokines & paracrine signaling.
MSCs do most of their work by secretion, not by becoming the tissue itself. They release cytokines — signaling proteins that suppress inflammation, recruit the body's own repair cells, and stimulate angiogenesis (new blood vessel formation) around damaged tissue. This paracrine effect is what allows a single administration to influence a much larger field of tissue than the injected cells alone could reach. Every cytokine profile is verified by an independent third-party laboratory before shipment.
Stem cells vs. exosomes
| Stem cells | Exosomes |
|---|---|
| Undifferentiated cells | Not cells — vesicles released by cells |
| Divide and differentiate | ~1/1000th the size of a cell; no DNA or mitochondria |
| Replace and rebuild tissue directly | Carry mRNA, proteins & microRNA between cells |
| Engraft at the treatment site | Travel to distant tissue, modulating behavior remotely |
PRP vs. UC-MSC therapy
| PRP therapy | UC-MSC therapy |
|---|---|
| Concentrated platelets from the patient's own blood | Living mesenchymal stem cells from donated cord tissue |
| Best for acute tendon, ligament & muscle injuries | Broader application in degenerative & systemic conditions |
| Works within days; 1–3 sessions typical | Peak results generally at 3–6 months |
| Enhances the body's own healing signal | Higher regenerative & anti-inflammatory potential |
Conditions Studied
Peer-reviewed applications across six systems.
This list reflects conditions studied in the peer-reviewed literature indexed by the National Library of Medicine — not a guarantee of outcome. Candidacy is always confirmed through medical screening.
Orthopedic & Musculoskeletal
05 conditions- Osteoarthritis
- Degenerative joint disease
- Rheumatoid arthritis
- Cartilage defects
- Bone fractures & non-union
Neurological
07 conditions- Spinal cord injuries
- Traumatic brain injury
- Chronic traumatic encephalopathy (CTE)
- Multiple sclerosis
- Alzheimer's disease
- Parkinson's disease
- Spinal muscular atrophy
Cardiovascular
06 conditions- Heart disease
- Stroke
- Ischemic heart disease
- Dilated cardiomyopathy
- Congestive heart failure
- Peripheral arterial disease
Metabolic, Organ & Respiratory
09 conditions- Type 1 & type 2 diabetes
- End-stage liver disease
- Liver cirrhosis
- Acute liver failure
- Chronic & acute kidney injury
- COPD
- Idiopathic pulmonary fibrosis
Autoimmune & Inflammatory
06 conditions- Chronic inflammatory systemic disease
- Systemic lupus erythematosus
- Sjögren's syndrome
- Crohn's disease
- Ulcerative colitis
- Cystic fibrosis
Regenerative & Other Applications
05 conditions- Burns
- Skin diseases
- Degenerative diseases
- Ischemic diseases
- Age-related macular degeneration
Applications in Practice
Where regeneration shows up first.
Orthopedic and sports-medicine applications carry the deepest evidence base — from cartilage regeneration to full alternative pathways around joint replacement surgery.
Joint & cartilage repair
MSCs differentiate into chondrocytes to rebuild damaged cartilage in the knees, shoulders, hips, ankles, elbows, hands and feet — while their anti-inflammatory secretions protect the cartilage that remains and improve synovial fluid quality.
Tendon & ligament injury
MSCs differentiate into tenocytes and ligament fibroblasts, strengthening collagen matrix and improving vascularization — accelerating recovery from tears and chronic overuse injury with a lower risk of re-injury.
Athletic recovery
Athletes use stem cell therapy to shorten downtime, strengthen vulnerable tissue proactively, and reduce the chronic inflammation that accumulates from repeated high-impact training and competition.
86% pain reduction at 12 months.
In controlled follow-up of intra-articular UC-MSC treatment for knee osteoarthritis, treated patients experienced an 86% reduction in pain and an 89% reduction in disability at 12 months — compared to 38% and 50% in the group treated with hyaluronic acid alone. Improvements remained stable over 7 years of follow-up, with no cases of severe adverse events, osteogenesis, or tumorigenesis.
A route around surgery — where appropriate.
Stem cell therapy cannot correct a structural or mechanical injury on its own. But for patients who are not surgical candidates, or who want to reduce dependence on corticosteroids, NSAIDs, or opioids for long-term pain management, it offers a less invasive option — and is often used post-operatively to accelerate healing as well.
Safety & Sourcing
Every product traced back to a single, screened donor.
Unmonitored clinics prioritize volume over viability. We exclusively partner with Latin America's leading stem cell production laboratory — over 14 years in stem cell research and development — and require independent third-party verification on every batch.
Donor screening standard
Umbilical cords are sourced from private birthing centers in Guadalajara, Mexico — not hospitals — following a healthy, live, full-term cesarean birth. Every donor must clear:
- 01 Age 18–24, first-time mother
- 02 No history of miscarriage or abortion
- 03 No history of drug or alcohol use
- 04 No SARS-CoV-2 vaccination or booster, verified by CURP registry
- 05 Full serological & infectious disease screening
- 06 Comprehensive clinical history review
Immune privileged, by design
UC-MSCs express low levels of MHC Class I molecules and no MHC Class II — allowing them to evade recognition by T-lymphocytes. That means no HLA matching, no blood products, and no meaningful risk of immune rejection with allogeneic (donor) administration.
"MSC administration was safe in different populations compared with other placebo modalities."
Wang, Yi & Song — Stem Cell Research & Therapy, 2021 meta-analysis of 62 randomized clinical trials, 3,546 participantsWhy Tijuana
A short drive from the U.S. border.
The FDA classifies cultured, expanded MSC therapy as a "drug" and has not approved it for the conditions in this list — leaving patients to seek regulated care abroad. Mexico, alongside Colombia and Panama, offers the same therapy 100% legally.
Why it isn't offered in the U.S.
The only FDA-approved stem cell treatment in the United States is hematopoietic (blood) stem cell transplantation for blood and immune cancers. Mesenchymal stem cell therapy for orthopedic, neurological, autoimmune and other chronic conditions remains classified as investigational — despite a decades-long regulatory stalemate and a growing body of international evidence.
World-class care, without the wait.
Tijuana has become a leading destination for medical tourism: modern facilities, physicians trained in the U.S. and Europe, appointment availability within days rather than months, and treatment costs a fraction of comparable care north of the border.
Handled, door to door.
Our patient concierge coordinates transportation and hotel accommodations ahead of your visit. Many patients combine treatment with a short recovery stay near the coast — typical lead time from approval to treatment is 2 weeks to 1 month.
The Facility
See where treatment happens.
A walkthrough of our partner clinic in Tijuana — the same private, cGMP-aligned facility where your consultation, labs and treatment take place.
The Process
From screening to treatment day.
A complimentary initial review starts the process — a full medical consultation follows, either virtually or in person, before any treatment is scheduled.
Screening application
A short intake form determines whether you're a reasonable candidate to begin the pre-treatment process.
Prerequisites
You'll receive a list of labs and intake forms that must be completed before final treatment clearance is issued.
Final medical review
Our medical team reviews everything submitted and either clears you to proceed or requests additional information.
Schedule treatment
Once approved, book your treatment date subject to availability — typical lead time is 2 weeks to 1 month, with concierge support arranged around your visit.
Pre- & Post-Treatment Protocol
- Smoking & alcohol — avoid for at least one week before and after treatment.
- NSAIDs — discontinue one week prior; avoid for two weeks after — they interfere with the inflammatory signaling MSCs rely on.
- Corticosteroid injections — none within three months prior to treatment.
- Prednisone — stop one week before; avoid for two weeks following treatment.
- Activity — rest for two weeks post-treatment, followed by a four-week guided physical rehabilitation protocol.
- Timeline — most patients reach optimal results between three and six months post-treatment.
Candidacy & Contraindications
- Patients with a cancer diagnosis within the past 5 years are not candidates for standard stem cell therapy — ask about our Natural Killer Cell and Dendritic Cell Therapy programs instead.
- Ideal dosage is calculated individually — factoring overall health, administration site(s), body weight, and condition severity.
- The type and severity of the condition being treated materially affects expected outcome; not every condition responds equally.
- All deposits are fully refundable up to 14 days before your scheduled date; rescheduling carries no extra charge.
- Treatment costs are not currently covered by insurance or Medicare, as therapy is classified as investigational in the U.S.
Frequently Asked
Every question we hear, organized.
Search or filter by topic — from the biology itself to what your trip to Tijuana actually looks like.
Stem Cells & ScienceWhat are mesenchymal stem cells (MSCs)?
Stem Cells & ScienceAre these embryonic stem cells?
Stem Cells & ScienceWhy umbilical cord–derived cells specifically?
Stem Cells & ScienceWhat's the difference between stem cells and exosomes?
Stem Cells & ScienceHow do stem cells actually reduce pain and inflammation?
Stem Cells & ScienceWhere do your stem cells come from?
Candidacy & TreatmentWhat conditions do you treat?
Candidacy & TreatmentWhat determines whether treatment will be effective for me?
Candidacy & TreatmentCan stem cell therapy help me avoid surgery?
Candidacy & TreatmentHow long do the effects of stem cell therapy last?
Candidacy & TreatmentHow is stem cell therapy different from PRP?
Candidacy & TreatmentWho is not a candidate for treatment?
Safety & SourcingIs stem cell therapy FDA approved?
Safety & SourcingHow are your donors screened?
Safety & SourcingWhat certifications and standards do you follow?
Safety & SourcingIs there a risk of immune rejection?
Cost & PoliciesIs treatment covered by insurance or Medicare?
Cost & PoliciesHow is pricing determined?
Cost & PoliciesWhat is your cancellation policy?
Visiting & LogisticsWhy is this treatment legal in Mexico but not the U.S.?
Visiting & LogisticsDo you help with travel and accommodations?
Visiting & LogisticsWhat should I do to prepare before treatment?
Visiting & LogisticsWhat does recovery look like after treatment?
Visiting & LogisticsDo I need a visa to visit Tijuana for treatment?
Getting StartedHow do I begin the process?
Getting StartedWhat is the patient evaluation form for?
Getting StartedCan I have prior imaging or records reviewed?
No questions match your search.
Get Started
Request your complimentary consultation.
Tell us about your condition and our medical team will follow up to schedule a virtual or in-person review — the first step of the screening process, at no cost.
A longer form — scroll within it to move through all sections. This is a draft placeholder; connect it to your patient-intake system before publishing live.